Table 2.

Correlation among WEM, DCP-VD and SCP-VD in different groups of patients with TAO

	SCP-VD (%)	Before adjusting		After adjusting*
		r	p		r	p
Whole ETDRS	46.20 ± 3.77	0.334	0.006		0.305	0.017
ParaFovea	46.04 ± 3.90	0.392	0.001		0.362	0.004
S-Hemi	45.38 ± 3.98	0.348	0.004		0.362	0.004
I-Hemi	16.10 ± 5.26	0.425	0.000		0.353	0.005
T-ETDRS	49.07 ± 4.36	0.336	0.006		0.326	0.010
S-ETDRS	49.09 ± 4.38	0.369	0.002		0.353	0.005
N-ETDRS	49.06 ± 4.46	0.281	0.023		0.306	0.016
I-ETDRS	48.02 ± 3.98	0.386	0.001		0.379	0.003
	DCP-VD (%)
Whole ETDRS	50.51 ± 3.96	0.053	0.677		0.046	0.723
ParaFovea	50.35 ± 4.13	0.098	0.439		0.081	0.535
S-Hemi	50.54 ± 3.56	0.085	0.503		0.07	0.593
I-Hemi	30.83 ± 5.98	0.115	0.364		0.088	0.498
T-ETDRS	53.18 ± 3.62	0.031	0.806		0.028	0.833
S-ETDRS	53.30 ± 3.50	0.139	0.271		0.063	0.631
N-ETDRS	53.06 ± 3.90	0.107	0.397		0.101	0.439
I-ETDRS	53.47 ± 3.37	0.129	0.307		0.113	0.385

The p-value indicated in bold meets the threshold of 0.05

*Age, gender, AL and bIOP were used as control variables to adjust the correlation analysis

WEM whole eye movement, SCP-VD superficial capillary plexus, DCP-VD deep capillary plexus, TAO thyroid-associated ophthalmopathy, ETDRS Early Treatment Diabetic Retinopathy Study, S superior, T temporal, N nasal, I inferior, Hemi hemisphere, AL axial length, bIOP biomechanically corrected intraocular pressure